Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product.

导出 LinkOut

翻译打印收藏纠错

第一作者： Neelima,Vidula

第一单位： Division of Hematology-Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA. Electronic address: neelima.vidula@ucsf.edu.

作者： Neelima,Vidula ^[1] ; Marcelo,Villa ^[2] ; Irene B,Helenowski ^[3] ; Mehboob,Merchant ^[2] ; Borko D,Jovanovic ^[3] ; Richard,Meagher ^[4] ; Jayesh,Mehta ^[5] ; Seema,Singhal ^[5] ; Jane N,Winter ^[5] ; Olga,Frankfurt ^[5] ; Jessica K,Altman ^[5] ; Stephanie F,Williams ^[6] ; Leo I,Gordon ^[5]

作者单位： Division of Hematology-Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA. Electronic address: neelima.vidula@ucsf.edu. ^[1] John and Lillian Mathews Center for Cellular Therapy, Northwestern University Feinberg School of Medicine, Chicago, IL. ^[2] Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. ^[3] Memorial Sloan-Kettering Cancer Center, New York, NY. ^[4] John and Lillian Mathews Center for Cellular Therapy, Northwestern University Feinberg School of Medicine, Chicago, IL; Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL. ^[5] Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL. ^[6]

关键词 Allogeneic transplantation Autologous transplantation Cardiopulmonary adverse events Infusion red blood cell volume Second transplant